unresectable locally advanced or metastatic, medullary thyroid carcinoma
Showing 1 - 1 of 1
Unresectable Locally Advanced or Metastatic, Medullary Thyroid Carcinoma Trial in Japan (Vandetanib 300mg)
Completed
- Unresectable Locally Advanced or Metastatic, Medullary Thyroid Carcinoma
- Vandetanib 300mg
-
Fukuoka-shi, Japan
- +3 more
Oct 11, 2016